Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -631 | -30,276 | N/A | N/A |
| Depreciation Amortization | 1,113 | 666 | N/A | N/A |
| Accounts receivable | -7,052 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,255 | 760 | N/A | N/A |
| Other Working Capital | -5,061 | 1,054 | N/A | N/A |
| Other Operating Activity | 10,136 | -532 | 0 | 0 |
| Operating Cash Flow | $-2,750 | $-28,328 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -16,967 | N/A | N/A | N/A |
| PPE Investments | -964 | -2,323 | N/A | N/A |
| Investing Cash Flow | $-17,931 | $-2,323 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 174 | 32 | N/A | N/A |
| Other Financing Activity | 45,365 | 87,317 | 0 | 0 |
| Financing Cash Flow | $45,539 | $87,349 | $N/A | $N/A |
| Beginning Cash Position | 60,949 | 4,251 | N/A | N/A |
| End Cash Position | 85,807 | 60,949 | N/A | N/A |
| Net Cash Flow | $24,858 | $56,698 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -2,750 | -28,328 | N/A | N/A |
| Capital Expenditure | -964 | -2,323 | N/A | N/A |
| Free Cash Flow | -3,714 | -30,651 | 0 | 0 |